Evidence supporting the use of: Monolaurin
For the health condition: Herpes

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Monolaurin, a monoglyceride derived from lauric acid (found in coconut oil), has been explored for its antiviral properties, including potential effects against Herpes simplex viruses (HSV-1 and HSV-2). The scientific justification for its use is based primarily on in vitro (test tube) studies and some animal research. These studies have shown that monolaurin can disrupt the lipid membranes of certain enveloped viruses, thereby inactivating them. Since HSV is an enveloped virus, this mechanism suggests a plausible antiviral action. However, clinical trials in humans specifically investigating monolaurin’s effectiveness in treating or preventing Herpes outbreaks are lacking.

A handful of laboratory studies have demonstrated that monolaurin can inactivate herpes viruses in cell cultures, and anecdotal reports suggest some people may experience reduced outbreak frequency. However, rigorous, placebo-controlled human studies are absent. Most available data come from basic science, not clinical application. Reviews of natural antiviral agents often mention monolaurin as a theoretically promising compound, but emphasize the need for more research before making firm recommendations.

In summary, while there is a scientific rationale and some preliminary laboratory evidence to support the use of monolaurin against Herpes, the lack of robust clinical trials limits confidence in its efficacy. It is rated a 2 out of 5 for evidence, reflecting promising but insufficient data for definitive support.

More about Monolaurin
More about Herpes